Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001962918-25-000036
Filing Date
2025-05-14
Accepted
2025-05-14 16:03:15
Documents
77
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q slrn-20250331.htm   iXBRL 10-Q 1398458
2 EX-31.1 slrn-20250331x10qexx311.htm EX-31.1 10757
3 EX-32.2 slrn-20250331x10qexx321.htm EX-32.2 6010
  Complete submission text file 0001962918-25-000036.txt   7217600

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT slrn-20250331.xsd EX-101.SCH 54697
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT slrn-20250331_cal.xml EX-101.CAL 70737
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT slrn-20250331_def.xml EX-101.DEF 250214
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT slrn-20250331_lab.xml EX-101.LAB 667109
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT slrn-20250331_pre.xml EX-101.PRE 482437
80 EXTRACTED XBRL INSTANCE DOCUMENT slrn-20250331_htm.xml XML 865188
Mailing Address 4149 LIBERTY CANYON RD. AGOURA HILLS CA 91301
Business Address 4149 LIBERTY CANYON RD. AGOURA HILLS CA 91301 805-456-4393
ACELYRIN, Inc. (Filer) CIK: 0001962918 (see all company filings)

EIN.: 852406735 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41696 | Film No.: 25945196
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)